A study of some bradykinin potentiating peptides derived from plasma proteins.
D000596:Amino Acids / Q000097:blood; D000806:Angiotensin-Converting Enzyme Inhibitors; D000818:Animals; D001011:Aorta / Q000187:drug effects; D001797:Blood Protein Electrophoresis; D001798:Blood Proteins / Q000494:pharmacology*; D001920:Bradykinin / Q000494:pharmacology*; D002850:Chromatography, Gel; D003331:Coronary Vessels / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D004386:Duodenum / Q000187:drug effects; D005260:Female; D005340:Fibrinogen / Q000302:isolation & purification; D006168:Guinea Pigs; D006801:Humans; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D008168:Lung / Q000187:drug effects; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D010455:Peptides / Q000097:blood / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D011930:Reaction Time / Q000187:drug effects; D012756:Sheep; D014599:Uterus / Q000187:drug effects; D014649:Vas Deferens / Q000187:drug effects
D000596:Amino Acids; D000806:Angiotensin-Converting Enzyme Inhibitors; D001798:Blood Proteins; D010455:Peptides; D005340:Fibrinogen; D001920:Bradykinin